Drug intelligence / Profile preview

TelomeScan

Development stage
Unknown
Lead developer
Oncolys BioPharma
Modality
Oncolytic Viruses → Oncolytic Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
In Vitro
01

Overview

TelomeScan (OBP-401) is a genetically engineered adenovirus type 5 designed for the detection of tumor cells. It utilizes the human telomerase reverse transcriptase (hTERT) gene promoter to drive selective viral replication in telomerase-positive cells, which are typically cancerous. The virus also contains a green fluorescent protein (GFP) gene under the control of a cytomegalovirus promoter, enabling visual identification of infected cancer cells through fluorescence. This approach allows for sensitive and specific detection of living circulating tumor cells (CTCs) in blood samples from cancer patients and can be used as a liquid biopsy tool for early diagnosis, monitoring therapeutic efficacy, detecting recurrence, and guiding therapy selection. OBP-1101 is an improved second-generation version addressing issues such as false negatives due to lack of adenovirus receptor on some cancer cells and false positives from certain white blood cells with hTERT activity[1][5][7].

Brand names
TelomeScan
02

Targets

Human telomerase reverse transcriptase promoter transcriptional machinery (hTERT promoter machinery)

Beyond the preview

Go deeper on TelomeScan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TelomeScan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call